Horizon Therapeutics (HZNP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
116.30 +0.05 (+0.04%) 10/05/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 116.30 unch (unch) -
for Thu, Oct 5th, 2023
Results
download Want to compare other data? Select Fields| Symbol | HZNP | ALNY | BNTX | ||
| Company | Horizon Therapeutics | Alnylam Pharmaceuticals | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 116.34 | 256.14 | 103.72 | ||
| High | 116.38 | 260.54 | 107.47 | ||
| Low | 116.26 | 253.83 | 103.45 | ||
| Last | 116.30 | 257.19 | 104.00 | ||
| Change | +0.05 | +2.34 | unch | ||
| % Change | +0.04% | +0.92% | unch | ||
| Volume | 28,881,200 | 941,500 | 1,272,000 | ||
| 20-Day Average Volume | 3,994,490 | 1,077,990 | 1,541,080 | ||
| Previous Close | 116.25 | 254.85 | 104.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 241.94 | 98.56 | ||
| 20-Day Raw Stochastic | 95.09% | 75.77% | 57.84% | ||
| 20-Day Relative Strength | 80.29% | 53.78% | 51.27% | ||
| Weighted Alpha | +49.30 | +27.42 | -3.89 | ||
| Today's Opinion | 88% Buy | 56% Sell | 40% Sell | ||
| Previous Opinion | 88% Buy | 56% Sell | 40% Sell | ||
| Last Month's Opinion | 40% Buy | 24% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +8.63% since 04/22/25 | -0.65% since 04/22/25 | ||
| Low | 115.66 on 09/29/23 | 238.62 on 04/24/25 | 93.17 on 04/25/25 | ||
| High | 116.38 on 10/05/23 | 260.54 on 04/29/25 | 120.62 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -4.20% since 03/28/25 | +9.53% since 03/28/25 | ||
| Low | 114.75 on 09/11/23 | 205.87 on 04/09/25 | 81.20 on 04/07/25 | ||
| High | 116.38 on 10/05/23 | 273.61 on 04/01/25 | 120.62 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -6.13% since 01/29/25 | -14.16% since 01/29/25 | ||
| Low | 98.80 on 08/03/23 | 205.87 on 04/09/25 | 81.20 on 04/07/25 | ||
| High | 116.38 on 10/05/23 | 300.90 on 03/24/25 | 124.98 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | -9.66% since 10/29/24 | -8.78% since 10/29/24 | ||
| Low | 90.56 on 05/16/23 | 205.87 on 04/09/25 | 81.20 on 04/07/25 | ||
| High | 116.38 on 10/05/23 | 300.90 on 03/24/25 | 129.27 on 01/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 33,456,562 | 24,956,982 | ||
| Shares Outstanding, K | 228,995 | 130,085 | 239,971 | ||
| Annual Sales | 3,629,040,000 | 2,248,240,000 | 2,976,970,000 | ||
| Annual Net Income | 521,480,000 | -278,160,000 | -719,920,000 | ||
| Last Quarter Sales | 944,960,000 | 593,170,000 | 1,265,910,000 | ||
| Last Quarter Net Income | 127,070,000 | -83,760,000 | 274,270,000 | ||
| 60-Month Beta | 1.03 | 0.30 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 0.06 on 02/13/25 | 1.15 on 03/10/25 | ||
| Latest Earnings Date | 11/01/23 | 05/01/25 | 05/05/25 | ||
| Most Recent Dividend | N/A | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 0.00 | 0.00 | ||